AAAAAA

   
Results: 1-14 |
Results: 14
Quality of life scores predict outcome in metastatic but not in early breast cancer
Authors: Coates, AS Hurny, C Peterson, HF Bernhard, J Castiglione-Gertsch, M Gelber, RD Goldhirsch, A
Citation: As. Coates et al., Quality of life scores predict outcome in metastatic but not in early breast cancer, BREAST, 10, 2001, pp. 164-170
Response shift in the perception of health for utility evaluation: an explorative investigation
Authors: Bernhard, J Lowy, A Maibach, R Hurny, C
Citation: J. Bernhard et al., Response shift in the perception of health for utility evaluation: an explorative investigation, EUR J CANC, 37(14), 2001, pp. 1729-1735
Clinical relevance of single item quality of life indicators in cancer clinical trials
Authors: Bernhard, J Sullivan, M Hurny, C Coates, AS Rudenstam, CM
Citation: J. Bernhard et al., Clinical relevance of single item quality of life indicators in cancer clinical trials, BR J CANC, 84(9), 2001, pp. 1156-1165
Communicating about cancer: patients' needs and caregivers' skills
Authors: Hurny, C
Citation: C. Hurny, Communicating about cancer: patients' needs and caregivers' skills, SUPP CARE C, 8(6), 2000, pp. 437-438
Response and palliation in a phase II trial of gemcitabine in hormone-refractory metastatic prostatic carcinoma
Authors: Morant, R Bernhard, J Maibach, R Borner, M Fey, MF Thurlimann, B Jacky, E Trinkler, F Bauer, J Zulian, G Hanselmann, S Hurny, C Hering, F
Citation: R. Morant et al., Response and palliation in a phase II trial of gemcitabine in hormone-refractory metastatic prostatic carcinoma, ANN ONCOL, 11(2), 2000, pp. 183-188
Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: The International Breast Cancer Study Group Trial VII
Authors: Crivellari, D Bonetti, M Castiglione-Gertsch, M Gelber, RD Rudenstam, CM Thurlimann, B Price, KN Coates, AS Hurny, C Bernhard, J Lindtner, J Collins, J Senn, HJ Cavalli, F Forbes, J Gudgeon, A Simoncini, E Cortes-Funes, H Veronesi, A Fey, M Goldhirsch, A
Citation: D. Crivellari et al., Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: The International Breast Cancer Study Group Trial VII, J CL ONCOL, 18(7), 2000, pp. 1412-1422
Quality-of-life scores predict outcome in metastatic but not early breast cancer
Authors: Coates, AS Hurny, C Peterson, HF Bernhard, J Castiglione-Gertsch, M Gelber, RD Goldhirsch, A
Citation: As. Coates et al., Quality-of-life scores predict outcome in metastatic but not early breast cancer, J CL ONCOL, 18(22), 2000, pp. 3768-3774
Attitudes and beliefs towards disease and treatment in patients with advanced cancer using anthroposophical medicine
Authors: von Rohr, E Pampallona, S van Wegberg, B Cerny, T Hurny, C Bernhard, J Helwig, S Heusser, P
Citation: E. Von Rohr et al., Attitudes and beliefs towards disease and treatment in patients with advanced cancer using anthroposophical medicine, ONKOLOGIE, 23(6), 2000, pp. 558-563
Association between immunity and prognostic factors in early stage breast cancer patients before adjuvant treatment
Authors: Sabbioni, MEE Siegrist, HP Bacchi, M Bernhard, J Castiglione, M Thurlimann, B Bonnefoi, H Perey, L Herrmann, R Goldhirsch, A Hurny, C
Citation: Mee. Sabbioni et al., Association between immunity and prognostic factors in early stage breast cancer patients before adjuvant treatment, BREAST CANC, 59(3), 2000, pp. 279-287
Experiences in the realisation of a research project on anthroposophical medicine in patients with advanced cancer
Authors: von Rohr, E Pampallona, S van Wegbeg, B Hurny, C Bernhard, J Heusser, P Cerny, T
Citation: E. Von Rohr et al., Experiences in the realisation of a research project on anthroposophical medicine in patients with advanced cancer, SCHW MED WO, 130(34), 2000, pp. 1173-1184
Quality of life in postmenopausal patients with breast cancer after failure of tamoxifen: Formestane versus megestrol acetate as second-line hormonaltreatment
Authors: Bernhard, J Castiglione-Gertsch, M Schmitz, SFH Thurlimann, B Cavalli, F Morant, R Fey, MF Bonnefoi, H Goldhirsch, A Hurny, C
Citation: J. Bernhard et al., Quality of life in postmenopausal patients with breast cancer after failure of tamoxifen: Formestane versus megestrol acetate as second-line hormonaltreatment, EUR J CANC, 35(6), 1999, pp. 913-920
Interaction of tamoxifen with concurrent cytotoxic adjuvant treatment affects lymphocytes and lymphocyte subsets counts in breast cancer patients
Authors: Sabbioni, MEE Castiglione, M Hurny, C Siegrist, HP Bacchi, M Bernhard, J Thurlimann, B Bonnefoi, H Perey, L Goldhirsch, A Senn, HJ
Citation: Mee. Sabbioni et al., Interaction of tamoxifen with concurrent cytotoxic adjuvant treatment affects lymphocytes and lymphocyte subsets counts in breast cancer patients, SUPP CARE C, 7(3), 1999, pp. 149-153
Quality of life as subjective experience: Reframing of perception in patients with colon cancer undergoing radical resection with or without adjuvantchemotherapy
Authors: Bernhard, J Hurny, C Maibach, R Herrmann, R Laffer, U
Citation: J. Bernhard et al., Quality of life as subjective experience: Reframing of perception in patients with colon cancer undergoing radical resection with or without adjuvantchemotherapy, ANN ONCOL, 10(7), 1999, pp. 775-782
Defining clinical benefit in postmenopausal patients with breast cancer under second-line endocrine treatment: Does quality of life matter?
Authors: Bernhard, J Thurlimann, B Schmitz, SFH Castiglione-Gertsch, M Cavalli, F Morant, R Fey, MF Bonnefoi, H Goldhirsch, A Hurny, C
Citation: J. Bernhard et al., Defining clinical benefit in postmenopausal patients with breast cancer under second-line endocrine treatment: Does quality of life matter?, J CL ONCOL, 17(6), 1999, pp. 1672-1679
Risultati: 1-14 |